相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activity of ceftazidime-avibactam against Escherichia coli isolates from US veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status
Brian D. Johnston et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)
In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017)
Wen-Chien Ko et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2020)
Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review
Ann E. Stapleton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Interplay between β-lactamases and new β-lactamase inhibitors
Karen Bush et al.
NATURE REVIEWS MICROBIOLOGY (2019)
In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015
Krystyna M. Kazmierczak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world
Yohei Doi et al.
JOURNAL OF TRAVEL MEDICINE (2017)
Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli
Hui-Hsiu Wu et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
Mechanisms of drug resistance: quinolone resistance
David C. Hooper et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS (2015)
In Vitro Antibacterial Activity of the Ceftazidime-Avibactam Combination against Enterobacteriaceae, Including Strains with Well-Characterized β-Lactamases
Premavathy Levasseur et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Trends in Susceptibility of Escherichia coli from Intra-Abdominal Infections to Ertapenem and Comparators in the United States According to Data from the SMART Program, 2009 to 2013
Sibylle H. Lob et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases
Krisztina M. Papp-Wallace et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
A New Clone Sweeps Clean: the Enigmatic Emergence of Escherichia coli Sequence Type 131
Ritu Banerjee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Escherichia coli ST131, an Intriguing Clonal Group
Marie-Helene Nicolas-Chanoine et al.
CLINICAL MICROBIOLOGY REVIEWS (2014)
Global dissemination of a multidrug resistant Escherichia coli clone
Nicola K. Petty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Trends in Human Fecal Carriage of Extended-Spectrum β-Lactamases in the Community: Toward the Globalization of CTX-M
Paul-Louis Woerther et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli
James R. Johnson et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor
David E. Ehmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Consensus statement on the role of fluoroquinolones in the management of urinary tract infections
Po-Ren Hsueh et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2011)
分享论文
